Showing results (371-380 of 635) with videos related to

Sort By:
Pageof 64
Pediatric Blood & Cancer|March 20, 2015
A child with Li-Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignanciesBrigitte Schlegelberger, Hans Kreipe, Ulrich Lehmann, et al.
Applied Clinical Informatics|May 21, 2026
Beyond the Model: Practical Insights from Monitoring Predictive Models Across Diverse Clinical WorkflowsJohn J Hanna, Christopher R Dennis, Andrew O Johnson, et al.
Translational Lung Cancer Research|December 4, 2018
Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and cliniciansMichael Allgäuer, Jan Budczies, Petros Christopoulos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2023
Tumour mutational burden and survival with molecularly matched therapyTill de Bortoli, Manuela Benary, Peter Horak, et al.
BMC Cancer|March 25, 2010
Identification of differentially expressed microRNAs in human male breast cancerUlrich Lehmann, Thomas Streichert, Benjamin Otto, et al.
Human Molecular Genetics|April 7, 2007
Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosisUlrich Lehmann, Luzie U Wingen, Kai Brakensiek, et al.
Cell Death & Disease|July 27, 2021
BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatmentStephanie Busche, Katharina John, Franziska Wandrer, et al.
Applied Clinical Informatics|March 24, 2025
Implementation and Adoption of an Order-Based Surgical Case Request Tool Across Subspecialty ClinicsAndrew Patrick Bain, Alyssa Low, Robert W Turer, et al.
Frontiers in Oncology|April 26, 2021
De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung CancerFarastuk Bozorgmehr, Daniel Kazdal, Inn Chung, et al.
European Urology Focus|November 28, 2018
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical ProstatectomyJoanne Nyarangi-Dix, Manuel Wiesenfarth, David Bonekamp, et al.
Pageof 64